Table: Taiko Pharmaceutical -Q1 group results

Taiko Pharmaceutical

10/08/2018 08:00

Aug 10 (Reuters)- 
             Taiko Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2018        Jun 30, 2017     Mar 31, 2019 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               1.27                1.40             9.36     
                   (-9.5 pct)          (+34.3 pct)      (-1.1 pct)  
  Operating          61 mln              181 mln           1.63     
                   (-66.0 pct)                          (-12.2 pct) 
  Recurring          28 mln              128 mln           1.43     
                   (-77.8 pct)                          (-8.8 pct)  
  Net                38 mln              99 mln            1.01     
                   (-61.1 pct)                          (-7.8 pct)  
  EPS               2.72 yen            7.07 yen         70.94 yen  
  EPS Diluted       2.72 yen            7.05 yen                    
  Ann Div                               25.00 yen        25.00 yen  
  -Q2 div                                  NIL           10.00 yen  
  -Q4 div                               25.00 yen        15.00 yen  
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T